Northwestern Mutual Wealth Management
CPRX

Northwestern Mutual Wealth Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.34K Sell
54
-346
-87% -$8.24K ﹤0.01% 3695
2025
Q4 		$9.34K Buy
400
+225
+129% +$5.01K ﹤0.01% 3018
2025
Q3 		$3.45K Buy
175
+29
+20% +$596 ﹤0.01% 3258
2025
Q2 		$3.17K Buy
+146
New +$3.45K ﹤0.01% 3141
2024
Q4 		– Sell
-133
Closed -$2.64K – 3660
2024
Q3 		$2.64K Buy
+133
New +$2.47K ﹤0.01% 3066
2024
Q2 		– Sell
-3
Closed -$48 – 3545
2024
Q1 		$48 Sell
3
-193
-98% -$2.91K ﹤0.01% 3475
2023
Q4 		$3.29K Buy
+196
New +$2.68K ﹤0.01% 2974
2023
Q1 		– Sell
-252
Closed -$4.69K – 3397
2022
Q4 		$4.69K Buy
252
+250
+12,500% +$3.85K ﹤0.01% 2741
2022
Q3 		$0 Hold
2
– – ﹤0.01% 3163
2022
Q2 		$0 Hold
2
– – ﹤0.01% 3218
2022
Q1 		$0 Buy
+2
New +$14 ﹤0.01% 3148
2021
Q4 		– Sell
-1
Closed – – 3164
2021
Q3 		$0 Buy
+1
New +$5 ﹤0.01% 3040
2018
Q2 		– Sell
-636
Closed -$2K – 2379
2018
Q1 		$2K Buy
+636
New +$2.11K ﹤0.01% 2029
2017
Q4 		– Sell
-500
Closed -$1K – 2317
2017
Q3 		$1K Buy
+500
New +$1.37K ﹤0.01% 2046

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Northwestern Mutual Wealth Management's CPRX Position: Q1 2026 in Review

Northwestern Mutual Wealth Management reduced its Catalyst Pharmaceutical (CPRX) stake by 87% in Q1 2026, selling an estimated $8.24K and leaving 54 shares worth $1.34K. The position accounts for ﹤0.01% of the portfolio, ranked #3695.

Northwestern Mutual Wealth Management first reported a position in CPRX in Q3 2017 and has held it in 14 quarters since. The position peaked at $9.34K in Q4 2025. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Northwestern Mutual Wealth Management held 54 shares of Catalyst Pharmaceutical worth $1.34K as of Q1 2026.
  • Northwestern Mutual Wealth Management sold 346 Catalyst Pharmaceutical shares in Q1 2026, an estimated $8.24K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3695 holding.
  • Northwestern Mutual Wealth Management first reported a position in Catalyst Pharmaceutical in Q3 2017 and has held it in 14 quarters since.
  • Northwestern Mutual Wealth Management's Catalyst Pharmaceutical position peaked at $9.34K in Q4 2025.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.